Statistics
Publications
142
Citations
18.7K
H-Index
57
Active since
2008
Bob T. Li is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and molecular oncology.
Publications per year
2008–2025
142
142
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
Ferdinandos Skoulidis, Bob T. Li, Grace K. Dy et al. · New England Journal of Medicine · 2021 · 1.8K citations · Full text
Medicine, Oncology, Pharmacology +17
KRAS <sup>G12C</sup> Inhibition with Sotorasib in Advanced Solid Tumors
David S. Hong, Marwan Fakih, John H. Strickler et al. · New England Journal of Medicine · 2020 · 1.7K citations · Full text
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi, Matthew T. Chang, Guotai Xu et al. · Cancer Cell · 2018 · 1K citations · Full text
Trastuzumab Deruxtecan in <i>HER2</i> -Mutant Non–Small-Cell Lung Cancer
Bob T. Li, Egbert F. Smit, Yasushi Goto et al. · New England Journal of Medicine · 2021 · 980 citations · Full text
Medicine, Oncology, Pharmacology +16
HER kinase inhibition in patients with HER2- and HER3-mutant cancers
David M. Hyman, Sarina A. Piha‐Paul, Helen Won et al. · Nature · 2018 · 783 citations
Medicine, Cancer Biology, Oncology +14
1–5 of 142